EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

Scottish Child Cancer Patients Missing out on Clinical Trials

CHILD cancer patients in Scotland are missing out on experimental treatments due to a lack of clinical trials, a study has found. Research presented at the National C...
Continue Reading →
Europe

CATALENT WINS PRESTIGIOUS ‘INNOVATION IN PROCESS AND FORMULATION DEVELOPMENT’ AWARD AT CPHI WORLDWIDE FOR ITS OPTISHELL™ SOFTGEL TECHNOLOGY

Somerset, N.J. & CPhI Worldwide, Madrid, Spain – October 14, 2015 — Catalent Pharma Solutions (Stand 3G10), the leading global provider of advanced delivery tech...
Continue Reading →
Europe

Savolitinib Completes Enrolment for Phase II Clinical Trial in Papillary Renal Cell Carcinoma

Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, and AstraZeneca AB (pu...
Continue Reading →
Europe

First clinical trial to strengthen babies bones in the womb

The first clinical trial injecting foetal stem cells into babies still in the womb is to start in January. The research will attempt to treat those destined to be bo...
Continue Reading →
Europe

Exco InTouch predicts strong growth in mobile ePRO

The cost and time efficient approach enables safe, secure collection of patient data, bolsters engagement and is applicable for both BYOD and provisioned devices    &...
Continue Reading →
Europe

Exco InTouch granted United States patent for groundbreaking mDNA® technology

21 July 2015 – Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, today annou...
Continue Reading →
Europe

CluePoints Chief Commercial Officer Named in PharmaVOICE 100

3 August 2015   Cambridge, MA - CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has today announced tha...
Continue Reading →
Catalyst: 12th January 2026
Quotient